Differential effects of interferon-ß1b on cytokine patterns of CD4+ and CD8+ T cells derived from RRMS and PPMS patients

Multiple Sclerosis Journal

Volumn 18, Issue 5, 2012, Pages 674-678

  Skrzipek, Sabine ^a   Vogelgesang, Antje ^a   Bröker, Barbara M ^a   Dressel, Alexander ^a  

^a UNIVERSITY OF GREIFSWALD   (Germany)

Author keywords

cytokines; interferon beta; primary progressive MS; relapsing remitting MS; T cells

Indexed keywords

BETA1 INTERFERON; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 17; INTERLEUKIN 4; INTERLEUKIN 5; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL CULTURE; CELL POPULATION; CELL PROLIFERATION; CONTROLLED STUDY; CYTOKINE RELEASE; DISEASE COURSE; HUMAN; HUMAN CELL; IN VITRO STUDY; MULTIPLE SCLEROSIS; T LYMPHOCYTE;

EID: 84860457204     PISSN: 13524585     EISSN: 14770970     Source Type: Journal    
DOI: 10.1177/1352458511427317     Document Type: Article

References (10)

1. Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. I. Clinical results of a multicenter, randomized, double-blind, placebo-controlled trial. The IFNB Multiple Sclerosis Study Group. Neurology. 1993 ; 43: 655-661
2. Rojas JI, Romano M, Ciapponi A, Patrucco L, Cristiano E. Interferon Beta for primary progressive multiple sclerosis. Cochrane Database Syst Rev. :
3. Sellebjerg F, Datta P, Larsen J, et al. Gene expression analysis of interferon-beta treatment in multiple sclerosis. Mult Scler. 2008 ; 14: 615-621
4. Dressel A, Mirowska-Guzel D, Gerlach C, Weber F. Migration of T-cell subsets in multiple sclerosis and the effect of interferon-beta1a. Acta Neurol Scand. 2007 ; 116: 164-168
5. Kraus J, Ling AK, Hamm S, Voigt K, Oschmann P, Engelhardt B. Interferon-beta stabilizes barrier characteristics of brain endothelial cells in vitro. Ann Neurol. 2004 ; 56: 192-205
6. Sospedra M, Martin R. Immunology of multiple sclerosis. Annu Rev Immunol. 2005 ; 23: 683-747
7. Axtell RC, de Jong BA, Boniface K, et al. T helper type 1 and 17 cells determine efficacy of interferon-beta in multiple sclerosis and experimental encephalomyelitis. Nat Med. 2010 ; 16: 406-412
8. van Boxel-Dezaire AHH, Zula JA, Xu Y, Ransohoff RM, Jacobberger JW, Stark GR. Major differences in the responses of primary human leukocyte subsets to IFN-beta. J Immunol. 2010 ; 185: 5888-5899
9. Sarchielli P, Critelli A, Greco L, Sokola E, Floridi A, Gallai V. Expression of TNF-alpha mRNA by peripheral blood mononuclear cells of multiple sclerosis patients treated with IFN-beta 1A. Cytokine. 2001 ; 14: 294-298
10. Hedegaard CJ, Krakauer M, Bendtzen K, Lund H, Sellebjerg F, Nielsen CH. T helper cell type 1 (Th1), Th2 and Th17 responses to myelin basic protein and disease activity in multiple sclerosis. Immunology. 2008 ; 125: 161-169